Hyperimmune anti-HBS plasma for the prevention of HBV recurrence after liver transplantation: Efficacy, safety, kinetics and economics in 26 patients during 14-year experience of two centers

被引:0
|
作者
Bihl, Florian K.
Gurtner, Vanina
Russman, Stefan
Di Giommarino, Loriana
Steineman, Claudia
Cerny, Andreas
Hadengue, Antoine
Majno, Pietro
Giostra, Emiliano
Castelli, Damiano
Mentha, Gilles
机构
[1] Univ Hosp Geneva, Dept Gastroenterol & Hepatol, Geneva, Switzerland
[2] Swiss Red Cross, Blood Transfus Serv, Lugano, Switzerland
[3] Univ Zurich Hosp, Dept Clin Pharmacol, CH-8091 Zurich, Switzerland
[4] Univ Lausanne Hosp, Dept Gastroenterol & Hepatol, Lausanne, Switzerland
[5] Clin Luganeses Moncucco, Hepatol Unit, Lugano, Switzerland
[6] Univ Hosp Geneva, Transplantat Unit, Geneva, Switzerland
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
528
引用
收藏
页码:472A / 472A
页数:1
相关论文
共 6 条
  • [1] Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation
    Florian Bihl
    Stefan Russmann
    Vanina Gurtner
    Loriana Di Giammarino
    Loredana Pizzi-Bosman
    Martine Michel
    Andreas Cerny
    Antoine Hadengue
    Pietro Majno
    Emiliano Giostra
    Damiano Castelli
    Gilles Mentha
    BMC Gastroenterology, 10
  • [2] Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation
    Bihl, Florian
    Russmann, Stefan
    Gurtner, Vanina
    Di Giammarino, Loriana
    Pizzi-Bosman, Loredana
    Michel, Martine
    Cerny, Andreas
    Hadengue, Antoine
    Majno, Pietro
    Giostra, Emiliano
    Castelli, Damiano
    Mentha, Gilles
    BMC GASTROENTEROLOGY, 2010, 10
  • [3] EFFICACY AND SAFETY OF PASTEURIZED INTRAMUSCULAR ANTI-HBS IMMUNOGLOBULINS FOR HBV RECURRENCE PROPHYLAXIS AFTER LIVER TRANSPLANTATION
    Carrai, Paola
    De Simone, Paolo
    Franchello, Alessandro
    Salizzoni, Mauro
    Filipponi, Franco
    LIVER TRANSPLANTATION, 2008, 14 (07) : S183 - S184
  • [4] Anti-HBs antibody reduction during prevention of HBV reactivation after liver transplantation-alternative concept for saving HBIg?
    Ishigami, Masatoshi
    Katano, Yoshiaki
    Hayashi, Kazuhiko
    Honda, Takashi
    Kuzuya, Teiji
    Ishizu, Yoji
    Goto, Hidemi
    HEPATOLOGY, 2012, 56 : 537A - 537A
  • [5] Anti-HBS and HBsAg kinetics during the first days after liver transplantation in patients receiving hepatitis B immune globulin for HBV reinfection prophylaxis: Evidence for an early accelerated administration scheme.
    Rosenau, J
    Tillmann, HL
    Wedemeyer, H
    Tietge, UJ
    Bahr, MJ
    Trautwein, C
    Boeker, KH
    Nashan, B
    Kuse, ER
    Klempnauer, J
    Manns, MP
    HEPATOLOGY, 2001, 34 (04) : 363A - 363A
  • [6] Prevention of hepatitis B reinfection after liver transplantation by post transplant long-term administration of GANCICLOVIR IV and anti-HBs immunoprophylaxis in patients at high risk of viral recurrence.
    Roche, B
    Samuel, D
    Feray, C
    Gigou, M
    Arulnaden, JL
    David, MF
    Bismuth, A
    Reynes, M
    Bismuth, H
    HEPATOLOGY, 1996, 24 (04) : 1765 - 1765